Bank of Montreal’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Bank of Montreal’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,875	Closed	-$34K	–	5497
2020 Q4	$34K	Buy	1,875 +1,305	+229%	+$23.8K	﹤0.01%	4155
2020 Q3	$10K	Sell	570 -399	-41%	-$6.71K	﹤0.01%	4152
2020 Q2	$15K	Buy	+969	New	+$13.8K	﹤0.01%	3998
2020 Q1	–	Sell	-1,515	Closed	-$25K	–	5013
2019 Q4	$25K	Buy	1,515 +454	+43%	+$7.57K	﹤0.01%	4202
2019 Q3	$16K	Buy	1,061 +39	+4%	+$526	﹤0.01%	4227
2019 Q2	$17K	Buy	+1,022	New	+$16.7K	﹤0.01%	4281
2019 Q1	–	Sell	-163	Closed	-$3K	–	4960
2018 Q4	$3K	Buy	163 +83	+104%	+$1.41K	﹤0.01%	4321
2018 Q3	$1K	Sell	80 -2	-2%	-$41	﹤0.01%	4661
2018 Q2	$2K	Buy	+82	New	+$1.54K	﹤0.01%	4453

Bank of Montreal's CBMG Position: Q1 2021 in Review

Bank of Montreal sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 1,875 shares — an estimated $34K sold.

Bank of Montreal first reported a position in CBMG in Q2 2018 and held it in 9 quarters. The position peaked at $34K in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

Bank of Montreal reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
Bank of Montreal sold 1,875 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $34K.
Bank of Montreal first reported a position in Cellular Biomedicine Group, Inc. in Q2 2018 and held it in 9 quarters.
Bank of Montreal's Cellular Biomedicine Group, Inc. position peaked at $34K in Q4 2020.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Bank of Montreal's 13F filing for Q1 2021, filed 13 May 2021.